RTOG 1005
A randomized phase III trial looking at
shortening the treatments for select women
with breast cancer.
http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1005
The NCI is scientifically looking into
ways to reduce the cost and inconvenience
of cancer care- this is one such trial.
RTOG 0413/NSABP B-39
A Randomized Phase III Study of Conventional
Whole Breast Irradiation (WBI) versus Partial
Breast Irradiation (PBI) for Women with
Stage 0, I, or II Breast Cancer
RTOG 0974/NSABP B-43
A Phase III Clinical Trial Comparing Trastuzumab
Given Concurrently with Radiation Therapy
and Radiation Therapy Alone for Women with
HER-2 Positive Ductal Carcinoma In Situ
Resected by Lumpectomy.
RTOG 0524
A Phase I/II Trial of a Combination of Paclitaxel
and Trastuzumab With Daily Irradiation or
Paclitaxel alone With Daily Irradiation
Following Transurethral Surgery for Non-Cystectomy
Candidates With Muscle-Invasive Bladder
RTOG 0933
A Phase II Trial of Hippocampal Avoidance
During Whole Brain Radiotherapy for Brain
Metastases--RTOG CCOP Study
RTOG 0436
A Phase III Trial Evaluating the Addition
of Cetuximab to Paclitaxel, Cisplatin, and
Radiation for Patients With Esophageal Cancer
Who Are Treated Without Surgery
RTOG 0848
A Phase III Trial Evaluating both Erlotinib
And Chemoradiation as Adjuvant Treatment
for Patients with Resected Head of Pancreas
Adenocarcinoma
RTOG 1010
A Phase III Trial Evaluating the Addition
of Trastuzumab to Trimodality Treatment
of Her2-Overexpressing Esophageal Adenocarcinoma
RTOG 0920
A Phase III Study of Postoperative Radiation
Therapy (IMRT) +/- Cetuximab for Locally-Advanced
Resected Head and Neck Cancer
RTOG 1016
Phase III Trial of Radiotherapy Plus Cetuximab
Versus Chemoradiotherapy in HPV-Associated
Oropharynx Cancer
RTOG 1012
Phase II Randomized Trial of Prophylactic
Manuka Honey for the Reduction of Chemoradiation
Therapy Induced Esophagitis-Related Pain
During the Treatment of Lung Cancer - RTOG
CCOP Study (open to U.S. sites only)
RTOG 1005
Evaluate the relative efficacy of 4 times
a day consumption of liquid or lozenge Manuka
honey to delay or prevent radiation esophagitis-related
pain (during combined chemotherapy and radiation
therapy for lung cnancer) as compared to
standard supportive treatment, as measured
at week 4 by Numerical Rating Pain Scale
(NRPS) for pain upon swallowing
http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1012
RTOG 0538
CALGB 30610/Endorsed Study: Phase III Comparison
of Thoracic Radiotherapy Regimens in Patients
with Limited Small Cell Lung Cancer Also
Receiving Cisplatin and Etoposide
RTOG 0813
Seamless Phase I/II Study of Stereotactic
Lung Radiotherapy (SBRT) for Early Stage,
Centrally Located, Non-Small Cell Lung Cancer
(NSCLC) in Medically Inoperable Patients
RTOG 0937
Randomized Phase II Study Comparing Prophylactic
Cranial Irradiation Alone To Prophylactic
Cranial Irradiation And Consolidative Extra-Cranial
Irradiation For Extensive Disease Small
Cell Lung Cancer (ED-SCLC)
Jefferson/Genentech #OSI4327s
A Phase II Study of Erlotinib (Tarceva)
and hypofractionated thoracic radiotherapy
for patients with advanced or inoperable
non-small lung cancer
RTOG 0938
Protocol Information A Randomized Phase
II Trial Of Hypofractionated Radiotherapy
For Favorable Risk Prostate Cancer-RTOG
CCOP Study.
This protocol examines the effect of
5 or 12 treatments of prostate radiotherapy,
by giving more dose per day, as an alternative
to standard fractionation treatments which
usually take between 40 and 45 treatments.
RTOG 0526
A Prospective Phase II Trial of Transperineal
Ultrasound-Guided Brachytherapy for Locally
Recurrent Prostate Adenocarcinoma Following
External Beam Radiotherapy
RTOG 0534
A Phase III Trial of Short Term Androgen
Deprivation With Pelvic Lymph Node or Prostate
Bed Only Radiotherapy (SPPORT) in Prostate
Cancer Patients With a Rising PSA After
Radical Prostatectomy
RTOG 0622
A Phase II Trial of Samarium 153 Followed
By Salvage Prostatic Fossa 3D-CRT or IMRT
Irradiation In High-Risk, Clinically Non-Metastatic
Prostate Cancer after Radical Prostatectomy
RTOG 0815
A Phase III Prospective Randomized Trial
of Dose-Escalated Radiotherapy with or without
Short-Term Androgen Deprivation Therapy
for Patients with Intermediate-Risk Prostate
Cancer
RTOG 0924
Androgen Deprivation Therapy and High Dose
Radiotherapy With or Without Whole-Pelvic
Radiotherapy in Unfavorable Intermediate
or Favorable High Risk Prostate Cancer:
A Phase III Randomized Trial
